Abstract

Treatment options for benign paragangliomas include surgery, radiotherapy (RT), stereotactic radiosurgery (SRS), and observation. Patients who are elderly, infirm, and have a limited life expectancy may be followed. This is also a reasonable option for younger, healthier patients who have no evidence of progression on serial computed tomography or magnetic resonance imaging. Patients who require intervention are treated with either RT (45 Gy/25 fractions) or SRS (12.5-15 Gy) if resection would result in significant morbidity such as permanent cranial nerve deficits. The probability of tumor stabilization or regression after RT or SRS exceeds 95% and the probability of a significant complication is remote.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.